IBA ProteusOne proton therapy system

January 29, 2020 — IBA (Ion Beam Applications S.A.) announced that it has signed a contract and received a major down payment for a ProteusONE solution financed by the International Charity Foundation Cartu, a charity organization in Georgia. The contract includes a clinical ProteusONE solution and an additional cyclotron that will be dedicated to scientific research. The proton therapy center will be installed at the campus of the new Kutaisi International University (KIU), located in Kutaisi, Ga., and the first patient treatment is scheduled for 2024.

The contract includes a long-term operation and maintenance agreement and the typical end-user price for a ProteusONE solution with a maintenance contract is between EUR 35 and 40 million. IBA has begun to recognize revenue for the contract in the 2019 financial year.

Including this order, IBA sold eight rooms in 2019, bringing its backlog to a record high of EUR 1.1 billion. The Company has also finalized the refinancing of its credit lines with a term loan facility and a revolving loan facility for a total of EUR 67 million, further strengthening its balance sheet and its capacity to continue investment in innovative research and development to drive future growth.

Olivier Legrain, chief executive officer of IBA, commented: “This collaboration with Cartu Foundation to bring proton therapy to Georgia further increases the reach of proton therapy around the world and demonstrates the appeal of IBA’s product offering. IBA’s Proteus®ONE solution is a unique and truly compact intensity modulated proton therapy (IMPT) system and, alongside its open gantry and track record of short installation time, is the solution of choice for an increasing number of hospitals globally. We look forward to working closely with the Cartu Foundation and the new Kutaisi International University to provide greater access to proton therapy for cancer patients in Georgia and the South Caucasus, and facilitate greater research into the modality such as FLASH irradiation and ARC Therapy in proton therapy.”

Alexander Tevzadze, rector of Kutaisi International University commented:Proton therapy is considered as a superior form of radiotherapy and represents a better treatment choice for many forms of cancer. We are excited to partner with IBA to bring proton therapy to Georgia as part of the proton therapy center at the Kutaisi International University. The unique configuration of IBA’s equipment and the additional cyclotron will offer us a comprehensive range of applications and will allow us to be at the forefront of proton therapy development and research, which perfectly fits the mission of Kutaisi International University. Also, our patients will be able to stay closer to home to receive treatment that was previously unavailable in the region.”

For more information: www.iba-worldwide.com

Related Content

News | Treatment Planning

February 2, 2024 — RaySearch Laboratories announced that the number of radiotherapy centers that have chosen RayStation ...

Time February 02, 2024
Feature | Radiation Oncology | By Melinda Taschetta-Millane

Over the past several years, technological advancements have driven the development of more precise and targeted ...

Time January 16, 2024
News | Magnetic Resonance Imaging (MRI)

January 11, 2024 — On January 9th, 2024, a scientific prototype for MRI-guided proton therapy was inaugurated in Dresden ...

Time January 11, 2024
News | Radiation Therapy

December 27, 2023 — Nationwide Children’s Hospital and The Ohio State University Comprehensive Cancer Center – Arthur G ...

Time December 27, 2023
Feature | Proton Therapy | By Christine Book

A University of Miami Radiation Oncology department summary noted: “In radiation oncology, the art of patient care meets ...

Time October 11, 2023
Videos | Proton Therapy

Tune in to ITN’s latest “One on One” video series with Michael Butkus, PhD, for insights into proton therapy ...

Time October 10, 2023
News | Proton Therapy

October 4, 2023 — RaySearch Laboratories AB has announced its expanded collaboration with P-Cure, aiming at enhancing ...

Time October 04, 2023
Feature | ASTRO | By Christine Book

September 26, 2023 — Ahead of the 65th American Society for Radiation Oncology Annual Meeting, ASTRO 2023, ITN’s ...

Time September 26, 2023
Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
News | Radiation Therapy

August 30, 2023 — A published study by researchers at the University of Cincinnati Cancer Center and Cincinnati Children ...

Time August 30, 2023
Subscribe Now